Treace Medical Concepts, Inc. TMCI Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$61.04M-3.5% | -$59M-17.7% | -$50.11M-1.9% | -$49.18M+7.2% | -$52.99M+4.9% | ||
| $9.06M-14.7% | $10.62M+5.7% | $10.05M+6.6% | $9.43M+5.1% | $8.97M+6.6% | ||
| $33.16M-1.9% | $33.82M-2.9% | $34.82M+0.3% | $34.73M+8.9% | $31.89M+4.2% | ||
| $480K+64.4% | $292K-2.0% | $298K+0.3% | $297K0.0% | $297K-0.3% | ||
| —— | —— | —— | —— | —— | ||
| -$306K-115% | $2.09M-78.6% | $9.76M+62.8% | $6M+42.2% | $4.22M-25.8% | ||
| -$1.57M+51.2% | -$3.22M— | —— | —— | —— | ||
| $314K+108% | -$3.8M-49.1% | -$2.55M-235% | $1.89M+124% | -$7.93M-504% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $695K+71.2% | $406K+23.0% | ||
| —— | —— | —— | —— | -$47K+51.5% | ||
| -$3.28M-2.2% | -$3.21M+31.9% | -$4.71M— | —— | —— | ||
| -$12.93M+19.0% | -$15.97M-31.4% | -$12.15M+18.5% | -$14.9M+42.1% | -$25.75M+30.7% | ||
| $13.04M-3.6% | $13.52M-4.8% | $14.19M-0.4% | $14.25M+27.1% | $11.21M-3.3% | ||
| $41.55M+2.4% | $40.57M-24.3% | $53.58M-26.7% | $73.12M+26.2% | $57.96M-19.0% | ||
| $7.33M-44.7% | $13.25M+89.1% | $7.01M+73.7% | $4.03M-86.4% | $29.72M-16.0% | ||
| $518K-5.1% | $546K+2.4% | $533K+77.7% | $300K-39.4% | $495K+15.7% | ||
| $708K-21.5% | $902K+5.1% | $858K— | —— | —— | ||
| —— | —— | —— | —— | $0— | ||
| $1.78M-14.7% | $2.09M+185% | $731K-1.1% | $739K+1,073% | $63K-60.6% | ||
| —— | —— | -$4.42M+56.3% | -$10.13M-351% | $4.04M+347% | ||
| $4.63M-7.4% | $5M+0.4% | $4.98M+0.3% | $4.96M+1.9% | $4.87M-1.8% | ||
| $41K-66.7% | $123K-64.5% | $346K-39.7% | $574K-35.3% | $887K-22.5% | ||
| $480K+64.4% | $292K-2.0% | $298K+0.3% | $297K0.0% | $297K-0.3% | ||
| —— | $2.74M+33.3% | $2.05M+50.0% | $1.37M+100% | $684.25K— | ||
| -$3.28M-2.2% | -$3.21M+31.9% | -$4.71M— | —— | —— | ||
| —— | —— | —— | —— | -$5.05M-131% | ||
| $2.22M-0.3% | $2.22M-35.2% | $3.43M— | —— | —— | ||
| -$1.61M-33.1% | -$1.21M-9.0% | -$1.11M-85.3% | -$598K+5.8% | -$635K-18.0% | ||
| —— | —— | —— | —— | $0— | ||
| $1.38M+50.9% | $916K+80.7% | $507K+417% | $98K— | —— | ||
| —— | $56.32M+33.3% | $42.24M+50.0% | $28.16M+100% | $14.08M— | ||
| -$3.28M-2.2% | -$3.21M+31.9% | -$4.71M— | —— | —— | ||
| —— | $0— | $0— | $0— | $0— | ||
| $1.56M+40.8% | $1.11M+47.3% | $752K+230% | $228K+407% | $45K— | ||
| -$25.96M+11.9% | -$29.49M-11.9% | -$26.34M+9.6% | -$29.15M+21.1% | -$36.96M+24.2% | ||
| -$25.96M+11.9% | -$29.49M-11.9% | -$26.34M+9.6% | -$29.15M+21.1% | -$36.96M+24.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Treace Medical Concepts, Inc. generate?
- Treace Medical Concepts, Inc. (TMCI) generated -$12.9M in operating cash flow over the trailing twelve months.
- What is Treace Medical Concepts, Inc.'s free cash flow?
- After $13.0M of capital expenditures, Treace Medical Concepts, Inc.'s free cash flow was -$26.0M over the trailing twelve months, up 29.8% year over year.
- Where does Treace Medical Concepts, Inc.'s cash flow data come from?
- Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
